Unknown

Dataset Information

ABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patients.


ABSTRACT: Identification and reversal of treatment resistance mechanisms of clinically refractory tumor cells is critical for successful cancer therapy. Here we show that ATP-binding cassette member B5 (ABCB5) identifies therapy-refractory tumor cells in colorectal cancer patients following fluorouracil (5-FU)-based chemoradiation therapy and provide evidence for a functional role of ABCB5 in colorectal cancer 5-FU resistance. Examination of human colon and colorectal cancer specimens revealed ABCB5 to be expressed only on rare cells within healthy intestinal tissue, whereas clinical colorectal cancers exhibited substantially increased levels of ABCB5 expression. Analysis of successive, patient-matched biopsy specimens obtained prior to and following neoadjuvant 5-FU-based chemoradiation therapy in

SUBMITTER: Wilson BJ 

PROVIDER: S-EPMC3395026 | biostudies-literature | 2011 Aug

REPOSITORIES: biostudies-literature